Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2017, Article ID 8184915, 10 pages
Research Article

The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada

1GlaxoSmithKline, Research Triangle Park, Durham, NC, USA
2GlaxoSmithKline, Mississauga, ON, Canada
3JSS Medical Research Inc., Saint Laurent, QC, Canada
4Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, USA
5GlaxoSmithKline, Collegeville, PA, USA
6McGill University, Montreal, QC, Canada

Correspondence should be addressed to John S. Sampalis; moc.hcraeserssj@snoissimbus

Received 18 January 2017; Revised 11 April 2017; Accepted 15 May 2017; Published 20 June 2017

Academic Editor: Angelo G. Corsico

Copyright © 2017 Tam Dang-Tan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Following adjustment for demographics, comorbidities and prior HCU, in patients who experienced an exacerbation or moderate exacerbation, HCU was higher during the 3 months after an exacerbation compared with pre-exacerbation HCU

  1. Supplementary Material